PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1401788
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1401788
Anti-Infective Agents Market size was valued at USD 1,37,461.03 Million in 2022, expanding at a CAGR of 4.2% from 2023 to 2030.
Anti-infectives, such as antibacterials, antivirals, antifungals, and antiparasitic drugs, are treatments that prevent or treat infections. Pre-clinical and clinical research on antimicrobials, antibacterials, antivirals, antifungals, and antiparasitic drugs is included in the category of anti-infective agents.
Anti-Infective Agents Market- Market Dynamics
Increasing prevalence of infectious disease and health consciousness to propel market demand
The Anti-Infective Agents market is also expected to increase as a result of growing health consciousness regarding the availability of infectious illness diagnostics and the preventable risks associated with early diagnosis. Infectious disorders, such as bacterial, viral, and fungal infections, continue to affect more people worldwide. To fight these illnesses, there is now a greater need for potent anti-infective medications. Effective anti-infective drugs are becoming more and more necessary because of the advent of novel infectious diseases or the resurgence of old ones. Some instances of these illnesses are the COVID-19 pandemic that occurred more recently, as well as the Ebola and Zika outbreaks. These incidents demonstrate how urgent it is to create and implement efficient remedies to control and treat these illnesses.
Anti-Infective Agents Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.2% over the forecast period (2023-2030)
Based on Type segmentation, antiviral was predicted to show maximum market share in the year 2022, owing to growing antiviral drug developments.
Based on Route of Administration segmentation, oral segment was the leading type in 2022, mainly due to rise in new product development.
Based on Distribution Channel segmentation, hospital pharmacies was the leading type in 2022, mainly due to growing demand from hospitalized patients.
On the basis of region, North America was the leading revenue generator in 2022, owing to improved healthcare infrastructure.
The Global Anti-Infective Agents Market is segmented on the basis of Type, Route of Administration, Distribution Channel, and Region.
The market is divided into three categories based on Type: antibacterial, antiviral, and antifungal. The antiviral segment dominates the market. The increased demand for antiviral drugs is expected to boost the demand for antiviral agents in the coming years.
The market is divided into three categories based on Route of Administration: topical, oral, intravenous. The oral segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to the growing focus on reducing oral therapies.
The market is divided into four categories based on Distribution Channel: hospital pharmacies, retail pharmacies, e-commerce, and others. The hospital pharmacies dominate the market and is likely to maintain its dominance during the forecast period. This is due to high demand patient treatment in hospitals is boosting the market growth.
Anti-Infective Agents Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Market players are increasing the range of products offered, R&D investments, and portfolio expansions as tactics to fortify their positions in the industry. Scientific, biotechnological, and pharmaceutical research developments have aided in the creation of novel anti-infective drugs. It entails identifying fresh targets for drugs, creating cutting-edge drug delivery methods, and employing cutting-edge diagnostic methods to diagnose illnesses more precisely. These factors ere expected to provide healthy competition among companies for market growth.
In January 2022, Mankind Pharma launched Saviour Mankind, its division focused on development of injectable medications for life-saving purposes. Its product portfolio includes a wide range of therapeutic solutions, from anti-infective agents.
The scope of this report covers the market by its major segments, which include as follows: